HPV vaccination (Gardasil) for cervical cancer prevention by Dr. P. Srilekha. Safe, effective and recommended for girls and women in Hyderabad.
Human Papillomavirus (HPV) is the cause of virtually all cervical cancers. The HPV vaccine (Gardasil 9) protects against 9 HPV types responsible for over 90% of cervical cancers and is most effective when given before sexual debut.
Dr. P. Srilekha offers HPV vaccination counselling and administration for girls from age 9, women up to 45 years, and advises on the catch-up schedule and the continuing importance of cervical screening even after vaccination.
Primary target age - 2 doses 6 months apart give optimal protection
3-dose schedule if not previously vaccinated
Shared decision-making about late vaccination benefit
3-dose schedule regardless of age for immune-compromised individuals
Vaccination after CIN treatment reduces recurrence risk
Vaccination does not replace cervical screening - both are needed
Age-appropriate discussion of vaccination benefits, schedule and side effects.
2-dose (9-14 years) or 3-dose (15+) schedule based on age and immune status.
Intramuscular injection in deltoid with post-vaccination observation for 15 minutes.
Completion of full schedule and reminder that cervical screening still required after vaccination.
MS (OBG) specialist with 4+ years dedicated to women health in Hyderabad
Treatment tailored to your age, diagnosis, and fertility plans
Comprehensive hormonal, ultrasound and imaging workup
Treatments designed to protect and support future fertility
Weekday and weekend slots available
A safe, respectful space where you feel heard and understood
Quick answers about this condition. Can't find what you need? Chat with us directly.
Gardasil 9 protects against 9 HPV strains — types 16, 18 (70% of cervical cancers), 31, 33, 45, 52, 58 (additional 15%), and types 6 and 11 (90% of genital warts).
Ideal age: 9–14 years (2-dose schedule) before sexual debut. Ages 15–45: 3-dose schedule (0, 2, 6 months). Benefits even for sexually active women.
No. Vaccination and screening are complementary. The vaccine does not cover all oncogenic HPV strains. Regular Pap smears/LBC remain essential.
Mild side effects: localised pain, redness, occasional mild fever. Serious reactions (anaphylaxis) are very rare. The vaccine is thoroughly safety-tested.
Not recommended during pregnancy. If you become pregnant between doses, complete remaining doses after delivery.
Book via WhatsApp +91 9963 138 139. Dr. Srilekha at Habsiguda, Hyderabad.